Liora Sagi

925 total citations
25 papers, 599 citations indexed

About

Liora Sagi is a scholar working on Genetics, Molecular Biology and Surgery. According to data from OpenAlex, Liora Sagi has authored 25 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 12 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Liora Sagi's work include Neurogenetic and Muscular Disorders Research (11 papers), RNA modifications and cancer (8 papers) and Congenital Anomalies and Fetal Surgery (7 papers). Liora Sagi is often cited by papers focused on Neurogenetic and Muscular Disorders Research (11 papers), RNA modifications and cancer (8 papers) and Congenital Anomalies and Fetal Surgery (7 papers). Liora Sagi collaborates with scholars based in Israel, United States and Italy. Liora Sagi's co-authors include Andreea Nissenkorn, Uri Kramer, Nathanel Zelnik, Bruria Ben Zeev, Hadassa Goldberg‐Stern, Aviva Fattal‐Valevski, Seth J. Baum, Henri Trau, Elina Liukkonen and Iván Sánchez Fernández and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Epilepsia and Muscle & Nerve.

In The Last Decade

Liora Sagi

24 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liora Sagi Israel 11 262 162 142 132 127 25 599
D Fontan France 14 185 0.7× 62 0.4× 149 1.0× 271 2.1× 51 0.4× 43 719
Karine Lascelles United Kingdom 16 109 0.4× 45 0.3× 136 1.0× 295 2.2× 47 0.4× 25 858
Paolo Curatolo Italy 13 247 0.9× 31 0.2× 62 0.4× 110 0.8× 59 0.5× 37 639
S. Ghariani Belgium 12 141 0.5× 23 0.1× 70 0.5× 176 1.3× 68 0.5× 27 600
Alexandre Rainha Campos Portugal 13 131 0.5× 94 0.6× 101 0.7× 108 0.8× 24 0.2× 30 540
Chun‐Fu Lin Taiwan 13 61 0.2× 35 0.2× 81 0.6× 135 1.0× 43 0.3× 56 650
José Pedro Vieira Portugal 15 131 0.5× 21 0.1× 108 0.8× 228 1.7× 179 1.4× 48 702
Aron J. Diament Brazil 14 143 0.5× 48 0.3× 75 0.5× 214 1.6× 18 0.1× 59 561
Rony Cohen Israel 13 127 0.5× 34 0.2× 34 0.2× 104 0.8× 38 0.3× 37 423
Iris Fried Israel 14 67 0.3× 391 2.4× 38 0.3× 148 1.1× 106 0.8× 28 763

Countries citing papers authored by Liora Sagi

Since Specialization
Citations

This map shows the geographic impact of Liora Sagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liora Sagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liora Sagi more than expected).

Fields of papers citing papers by Liora Sagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liora Sagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liora Sagi. The network helps show where Liora Sagi may publish in the future.

Co-authorship network of co-authors of Liora Sagi

This figure shows the co-authorship network connecting the top 25 collaborators of Liora Sagi. A scholar is included among the top collaborators of Liora Sagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liora Sagi. Liora Sagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lavie, Moran, Keren Armoni Domany, Inbal Golan‐Tripto, et al.. (2024). Respiratory outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy: national real-world cohort study. European Journal of Pediatrics. 184(1). 58–58. 2 indexed citations
2.
Unger, Tamar, Shira Albeck, Gary Weisinger, et al.. (2024). Treating late-onset Tay Sachs disease: Brain delivery with a dual trojan horse protein. Molecular Therapy — Methods & Clinical Development. 32(3). 101300–101300. 2 indexed citations
3.
Lubetzky, Ronit, et al.. (2023). Glucagon-like peptide-1 analog therapy in rare genetic diseases: monogenic obesity, monogenic diabetes, and spinal muscular atrophy. Acta Diabetologica. 60(8). 1099–1108. 5 indexed citations
4.
Latzer, Itay Tokatly, et al.. (2023). Real-Life Outcome After Gene Replacement Therapy for Spinal Muscular Atrophy: A Multicenter Experience. Pediatric Neurology. 144. 60–68. 8 indexed citations
5.
Magen, Iddo, Sharon Aharoni, Itay Tokatly Latzer, et al.. (2022). Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients. European Journal of Neurology. 29(8). 2420–2430. 20 indexed citations
7.
Yerushalmy‐Feler, Anat, Liora Sagi, Aviva Fattal‐Valevski, et al.. (2021). Nutritional Therapy in Children With Spinal Muscular Atrophy in the Era of Nusinersen. Journal of Pediatric Gastroenterology and Nutrition. 72(6). e154–e160. 10 indexed citations
9.
Brener, Avivit, et al.. (2020). The endocrine manifestations of spinal muscular atrophy, a real-life observational study. Neuromuscular Disorders. 30(4). 270–276. 9 indexed citations
10.
Brener, Avivit, et al.. (2020). Insulin-like growth factor-1 status is associated with insulin resistance in young patients with spinal muscular atrophy. Neuromuscular Disorders. 30(11). 888–896. 14 indexed citations
11.
Lavie, Moran, et al.. (2020). Nusinersen for spinal muscular atrophy type 1: Real‐world respiratory experience. Pediatric Pulmonology. 56(1). 291–298. 38 indexed citations
12.
Latzer, Itay Tokatly, et al.. (2019). Prediction of Drug-Resistant Epilepsy in Children With Cerebral Palsy. Journal of Child Neurology. 35(3). 187–194. 21 indexed citations
13.
Mashiah, Jacob, Avikam Harel, Liora Sagi, et al.. (2015). Isotretinoin treatment of autosomal recessive congenital ichthyosis complicated by coexisting dysferlinopathy. Clinical and Experimental Dermatology. 41(4). 390–393. 3 indexed citations
14.
Sagi, Liora, Michal Solomon, Seth J. Baum, et al.. (2011). Evidence for Methotrexate as a Useful Treatment for Steroid-dependent Chronic Urticaria. Acta Dermato Venereologica. 91(3). 303–306. 30 indexed citations
15.
Sagi, Liora, Seth J. Baum, Nancy Agmon‐Levin, et al.. (2011). Autoimmune bullous diseases. Autoimmunity Reviews. 10(9). 527–535. 58 indexed citations
16.
Sagi, Liora, et al.. (2010). The role of therapeutic plasma exchange in pemphigus vulgaris. Journal of the European Academy of Dermatology and Venereology. 25(1). 82–86. 10 indexed citations
17.
Fattal‐Valevski, Aviva, et al.. (2010). Botulinum Toxin A Injections to the Upper Limbs in Children With Cerebral Palsy: Duration of Effect. Journal of Child Neurology. 26(2). 166–170. 8 indexed citations
18.
Sagi, Liora, Boaz Amichai, A Barzilai, Rony Weitzen, & Heidi A. Trau. (2008). Pancreatic panniculitis and carcinoma of the pancreas. Clinical and Experimental Dermatology. 34(5). e205–e207. 9 indexed citations
19.
Kramer, Uri, Liora Sagi, Hadassa Goldberg‐Stern, et al.. (2008). Clinical spectrum and medical treatment of children with electrical status epilepticus in sleep (ESES). Epilepsia. 50(6). 1517–1524. 146 indexed citations
20.
Sagi, Liora, Nehama Zuckerman‐Levin, Aneta Gawlik, et al.. (2006). Clinical Significance of the Parental Origin of the X Chromosome in Turner Syndrome. The Journal of Clinical Endocrinology & Metabolism. 92(3). 846–852. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026